Publications
- Inhibitor of PCSK9 protein - alirocumab in clinical trials, ODYSSEY program2018 | First Faculty of Medicine
- Metabolism and sex, sex and metabolism2017 | First Faculty of Medicine
- Statin intolerance - finding practical solutions2017 | First Faculty of Medicine
- Present and future treatment of hyperlipoproteinemia and dyslipidemia in everyday practice2017 | First Faculty of Medicine
- Food supplements in dyslipidemia therapy - ArmoLIPID PLU2017 | First Faculty of Medicine
- Hypolipidemic and antihypertensive therapy in diabetic patients in the Czech Republic: notes on the VZP (General Health Insurance Company) Data +12015 | First Faculty of Medicine, Second Faculty of Medicine
- LDL-cholesterol: the lower the better! We need a new lipid lowering drugs? Focus on alirokumab (Praluent)2015 | First Faculty of Medicine
- Dyslipidemia - this time really only practical2013 | First Faculty of Medicine
- Commentary to Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: a therapeutic dilemma2010 | First Faculty of Medicine
- Pharmacotherapy of dyslipidemia +12009 | First Faculty of Medicine
Loading network view...